These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31533761)

  • 41. The genetic and biochemical basis of trimethylaminuria in an Irish cohort.
    Doyle S; O'Byrne JJ; Nesbitt M; Murphy DN; Abidin Z; Byrne N; Pastores G; Kirk R; Treacy EP
    JIMD Rep; 2019 May; 47(1):35-40. PubMed ID: 31240165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort.
    Akerman BR; Lemass H; Chow LM; Lambert DM; Greenberg C; Bibeau C; Mamer OA; Treacy EP
    Mol Genet Metab; 1999 Sep; 68(1):24-31. PubMed ID: 10479479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene.
    Lambert DM; Mamer OA; Akerman BR; Choinière L; Gaudet D; Hamet P; Treacy EP
    Mol Genet Metab; 2001 Jul; 73(3):224-9. PubMed ID: 11461189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A flow injection electrospray ionization tandem mass spectrometric method for the simultaneous measurement of trimethylamine and trimethylamine N-oxide in urine.
    Johnson DW
    J Mass Spectrom; 2008 Apr; 43(4):495-9. PubMed ID: 17975851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients.
    Yamazaki H; Fujieda M; Togashi M; Saito T; Preti G; Cashman JR; Kamataki T
    Life Sci; 2004 Apr; 74(22):2739-47. PubMed ID: 15043988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid screening assay of trimethylaminuria in urine with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Hsu WY; Lo WY; Lai CC; Tsai FJ; Tsai CH; Tsai Y; Lin WD; Chao MC
    Rapid Commun Mass Spectrom; 2007; 21(12):1915-9. PubMed ID: 17510942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.
    Fennema D; Phillips IR; Shephard EA
    Drug Metab Dispos; 2016 Nov; 44(11):1839-1850. PubMed ID: 27190056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome.
    Dolphin CT; Janmohamed A; Smith RL; Shephard EA; Phillips IR
    Nat Genet; 1997 Dec; 17(4):491-4. PubMed ID: 9398858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trimethylaminuria.
    Brewster MA; Schedewie H
    Ann Clin Lab Sci; 1983; 13(1):20-4. PubMed ID: 6838148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease.
    Brugère JF; Borrel G; Gaci N; Tottey W; O'Toole PW; Malpuech-Brugère C
    Gut Microbes; 2014; 5(1):5-10. PubMed ID: 24247281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.
    Zhou J; Shephard EA
    Mutat Res; 2006 Jun; 612(3):165-171. PubMed ID: 16481213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria.
    Forrest SM; Knight M; Akerman BR; Cashman JR; Treacy EP
    Pharmacogenetics; 2001 Mar; 11(2):169-74. PubMed ID: 11266081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Nose Knows… or Does it? Olfactory Reference Syndrome in Patients Presenting for Assessment of Unusual Body Odor.
    McNiven V; Mamane S; Zai G; So J
    J Nerv Ment Dis; 2019 Mar; 207(3):145-151. PubMed ID: 30720598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1H-NMR analysis of trimethylamine in urine for the diagnosis of fish-odour syndrome.
    Maschke S; Wahl A; Azaroual N; Boulet O; Crunelle V; Imbenotte M; Foulard M; Vermeersch G; Lhermitte M
    Clin Chim Acta; 1997 Jul; 263(2):139-46. PubMed ID: 9246418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.
    Yeung CK; Adman ET; Rettie AE
    Arch Biochem Biophys; 2007 Aug; 464(2):251-9. PubMed ID: 17531949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trimethylaminuria: the fish malodor syndrome.
    Mitchell SC; Smith RL
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):517-21. PubMed ID: 11259343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.
    Treacy EP; Akerman BR; Chow LM; Youil R; Bibeau C; Lin J; Bruce AG; Knight M; Danks DM; Cashman JR; Forrest SM
    Hum Mol Genet; 1998 May; 7(5):839-45. PubMed ID: 9536088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trimethylaminuria, fish odour syndrome: a new method of detection and response to treatment with metronidazole.
    Treacy E; Johnson D; Pitt JJ; Danks DM
    J Inherit Metab Dis; 1995; 18(3):306-12. PubMed ID: 7474897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel variants in outer protein surface of flavin-containing monooxygenase 3 found in an Argentinian case with impaired capacity for trimethylamine N-oxygenation.
    Dionisio L; Shimizu M; Stupniki S; Oyama S; Aztiria E; Alda M; Yamazaki H; Spitzmaul G
    Drug Metab Pharmacokinet; 2020 Aug; 35(4):383-388. PubMed ID: 32653296
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.